Yanfei Ye
5 Papers
Yanfei Ye is an academic researcher. The author has contributed to research in topics: Chemistry & Apoptosis. The author has co-authored 3 publications.
Chat about Author
Papers
Discovery of β-cyclocitral-derived mono-carbonyl curcumin analogs as anti-hepatocellular carcinoma agents via suppression of MAPK signaling pathway.
Haoyi Han,Ali Mohammed Mohammed Alsayed,Yi Wang,Qi Yan,Ancheng Shen,Jianxia Zhang,Yanfei Ye,Zhiguo Liu,Kun Wang,Xiaohui Zheng +9 more
TL;DR: In this article , a series of β-cyclocitral-derived mono-carbonyl curcumin analogs were synthesized and their anticancer properties were evaluated.
9
cyy260 suppresses the proliferation, migration and tumor growth of osteosarcoma by targeting PDGFR-β signaling pathway.
Yinda Qiu,Hao Yang,Ruiling Zheng,Xiaojing Chen,Yi Wang,Qi Yan,Yanfei Ye,Jianxia Zhang,H Y Han,Kun Wang,Yunjie Zhao,Lehao Huang,Xiaokun Li,Zhiguo Liu +13 more
TL;DR: Zhang et al. as mentioned in this paper investigated the antitumor effect and underlying mechanism of cyy260 in osteosarcoma via suppressing PDGFR-β and its downstream pathway.
7
Discovery of β-ionone derived chalcones as potent anti-aging agents
Yanyan Wang,Xingrong Fan,Jianxia Zhang,Yanfei Ye,Sun Xing,Qianqian Zhu,Huamao Yang,Zefeng Ni,Kun Wang,Chengxi Jiang +9 more
TL;DR: In this article , a β-ionone-based compound 5d was identified as the most active anti-aging agent. But, 5d exhibited excellent free radical-scavenging ability in vitro, and improved the athletic ability and lifespan of Drosophila in vivo.
1
Curcumin-Piperlongumine Hybrid Molecule Increases Cell Cycle Arrest and Apoptosis in Lung Cancer through JNK/c-Jun Signaling Pathway.
Qianwen Zhang,Min Hui,Guo Chen,Huijing Huang,Shiyu Wang,Yanfei Ye,Yan Wang,Mengying Wang,Shuyuan Zhang,Lehao Huang,Fangjun Zhang,Zhiguo Liu +11 more
TL;DR: Curcumin-piperlongumine hybrid molecule increases cell cycle arrest and apoptosis in lung cancer through JNK/c-Jun signaling pathway.
1
Corrigendum to "Design, synthesis, and biological evaluation of 1,6-naphthyridine-2-one derivatives as novel FGFR4 inhibitors for the treatment of colorectal cancer" [Eur. J. Med. Chem. 259 (2023) 115703/5].
Bo Fang,Yinshuang Lai,Hao Yan,Yue Ma,Zefeng Ni,Qianqian Zhu,Jianxia Zhang,Yanfei Ye,Mengying Wang,Peipei Wang,Yan Wang,Shuyuan Zhang,Min Hui,Dalong Wang,Yunjie Zhao,Xiaokun Li,Kun Wang,Zhiguo Liu +17 more
- 01 Feb 2024